Back to Journals » Therapeutics and Clinical Risk Management » Volume 11 » Bivalirudin plus loading dose of cilostazol-based triple-antiplatelet in treatment of non-ST-elevation myocardial infarction following percutaneous coronary intervention
Please verify you are not a robot.